V

Vanda Pharmaceuticals
D

VNDA

4.04000
USD
-0.19
(-4.49%)
Post Trading·4.04000USD0.00000(0.00%)
Last updated: · Delayed 15 min
Volume
41,984
EPS
-3
Div Yield
-
P/E
-1
Market Cap
244,269,255
Overview
Related Instruments
AMGN
AMGN
D
Amgen
432.57
-1.45(-0.33%)
AZN
AZN
D
AstraZeneca PLC
165.415
-1.315(-0.79%)
164.280-1.135(-0.69%)
BMY
BMY
D
Bristol-Myers Squibb Co
59.840
-0.740(-1.22%)
59.950+0.110(+0.18%)
GSK
GSK
D
GSK plc
49.500
0.480(0.98%)
LLY
LLY
D
Eli Lilly & Co
1,257.02
4.78(0.38%)
MRK
MRK
D
Merck & Co
145.970
0.680(0.47%)
145.400-0.570(-0.39%)
NVS
NVS
D
Novartis AG
150.580
0.230(0.15%)
148.880-1.700(-1.13%)
PFE
PFE
D
Pfizer
29.570
0.140(0.48%)
29.5700.000(0.00%)
SNY
SNY
D
Sanofi ADS
40.590
0.315(0.78%)
More

Title: Vanda Pharmaceuticals

Sector: Healthcare
Industry: Biotechnology
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include ASO Molecules, VQW-765, Tradipitant, and VTR-297. The maximum of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.
Smarter Decisions,Together
FacebookTwitterYoutubeInstagramLinkedIn
App Store
iOS
Google Play
Android

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.